Lab Reagents
Human IgG antibody Laboratories manufactures the sars cov 1 test reagents distributed by Genprice. The Sars Cov 1 Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars products are available in stock. Specificity: Sars Category: Cov Group: 1 Test
1 Test information
SARS-CoV Envelope Antibody |
3533-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
SARS-CoV Envelope Antibody |
3533-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
Description: SARS Envelope Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.Envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. |
Anti-SARS-CoV-2 Neutralization Antibody Test Kit (Enzyme-linked immunosorbent assay) |
CP04012 |
UnScience |
96T/5*96T |
Ask for price |
Description: It is a semi quantitative competition ELISA kit to detect the Anti-SARS-CoV-2 Neutralization Antibody in human serum or plasma. The micro test plate provided in this kit is pre-coated with recombinant human ACE2. During the reaction, the SARS-CoV-2 neutralization antibody in the standard & sample diluent pretreated samples or controls competes with a fixed amount of human ACE2 on the solid phase supporter for sites on the Horseradish peroxidase (HRP) conjugated recombinant SARS-CoV-2 RBD fragment (HRP-RBD). After 37℃incubation, the unbound HRP-RBD as well as any HRP-RBD bound to non-neutralization antibody will be captured on the plate and eventually form the ACE2-RBD-HRP complex, while the circulating neutralization antibodies HRP-RBD complexes remain in the supernatant and are removed during washing. Then a TMB substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. |
NATtrol Zika Virus Stock (Qualitative) (1 mL) |
TEST |
Zeptometrix |
1 mL |
EUR 1106.64 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |
SARS-CoV spike protein Antibody |
abx023139-100ug |
Abbexa |
100 ug |
EUR 857 |
|
SARS-CoV spike protein Antibody |
abx023143-100ug |
Abbexa |
100 ug |
EUR 857 |
|
Anti-SARS-CoV-2 Antibody |
A2061-50 |
Biovision |
50 µg |
EUR 480 |
Recombinant Coronavirus Nucleoprotein (SARS-CoV) |
P1509-10 |
Biovision |
10µg |
EUR 551 |
SARS-CoV-2 Spike Peptide |
9083P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (NT) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Spike Peptide |
9087P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (CT) SARS-CoV-2 Spike RBD peptide |
SARS-CoV-2 Spike Peptide |
9091P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (IN) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Spike Peptide |
9095P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (IN) SARS-CoV-2 Spike peptide |
SARS-CoV-2 Nucleocapsid Peptide |
9099P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (IN) SARS-CoV-2 Nucleocapsid peptide |
SARS-CoV-2 Nucleocapsid Peptide |
9103P |
ProSci |
0.05 mg |
EUR 196.25 |
Description: (CT) SARS-CoV-2 Nucleocapsid peptide |
SARS-CoV Nucleocapsid Recombinant Protein |
11-173 |
ProSci |
0.1 mg |
EUR 626.75 |
Description: Nucleocapsid (N) protein is the most abundant protein found in coronavirus. CoV N protein is a highly immunogenic phosphoprotein important for viral genome replication and modulation of cell signaling pathways. It was first identified by a research team while they were screening for ADP-ribosylated proteins during coronavirus (CoV) infection (Grunewald M. E., et al. 2017, Virology; 517: 62-68). The array of diverse functional activities accommodated in N protein makes it more than a structural protein but also an interesting target in the development of antiviral therapeutics. Because of the conservation of N protein sequence and its strong immunogenicity, N protein of coronavirus is chosen as a diagnostic tool. |